A second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech updates
Adobe
By Meghana Keshavan
May 4, 2026
Biotech Correspondent
Meghana Keshavan
UniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news
AbbVie buys Apogee Therapeutics, LSD therapy Phase 3 results, and more biotech news from The Readout
Moderna still bullish on mRNA, Ipsen's acquisition of Kartos, and more biotech news from The Readout
Trial results for Lilly's "triple-G" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout
FDA's top gene therapy regulator steps down, Trump's plan to lower GLP-1 prices, and more biotech news
Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout
